The effect of chemotherapy combined with recombination mutant human tumor necrosis factor on advanced cancer

The effect of chemotherapy combined with recombination mutant human tumor necrosis factor on advanced cancer

<p>Abstract</p> <p>Background</p> <p>Past studies suggested that tumor necrosis factor (TNF) assisted anti-tumor treatment and intensified the sensitivity of chemotherapy. However its clinical application has been curbed because of its low purity, high dosage, and stron...

Full description

Bibliographic Details
Main Authors:	Huang Changmin, Wu Xinyuan, Lu Huishan, Zheng Zhi-weng, Zhang Xiang-fu, Liu Xing, Wang Chuan, Guang Guoxiang
Format:	Article
Language:	English
Published:	BMC 2004-10-01
Series:	Journal of Translational Medicine
Subjects:	Tumor Tumor necrosis factor Biological therapy Chemotherapy Complex therapy
Online Access:	http://www.translational-medicine.com/content/2/1/33

Similar Items

Skin necrosis of penis after chemotherapy regimen in patients with resistant nonseminomatous testicular tumor
by: Stijelja Borislav, et al.
Published: (2006-01-01)

Effects of different levels of TGF-β expression and tumor cell necrosis rates in osteosarcoma on the chemotherapy resistance of osteosarcoma
by: Ling Zhou, et al.
Published: (2020-08-01)

Lung autotransplantation for bronchial necrosis after radiotherapy: a case report
by: Yuya Nobori, et al.
Published: (2021-04-01)

Safe eradication of large established tumors using neovasculature‐targeted tumor necrosis factor‐based therapies
by: Leander Huyghe, et al.
Published: (2020-02-01)

Avascular Necrosis of Bone following Chemotherapy in Cancer Patients with Coagulopathy: Report of Two Cases
by: Hui-Ching Hsu, et al.
Published: (2018-03-01)

Blockade of ALDH in Cisplatin-Resistant Ovarian Cancer Stem Cells In Vitro Synergistically Enhances Chemotherapy-Induced Cell Death
by: Guo, F., et al.
Published: (2022)

Expression of tumor necrosis factor-alpha and receptor I(P55)in pterygium
by: Bing Wu, et al.
Published: (2014-06-01)

Anti-Tumor Necrosis Factor-alpha in therapy of severe alcoholic hepatitis: a case report
by: M. Romano, et al.
Published: (2013-05-01)

Effects of tumor necrosis factor-alpha on glucose uptake in primary cultured rat astrocytes.
Published: (2005)

Single Posterior Approach for Resection and Stabilization for Locally Advanced Pancoast Tumors Involving the Spine: Single Centre Experience
by: Fahed Zairi, et al.
Published: (2016-12-01)

Suppression of Transmembrane Tumor Necrosis Factor Alpha Processing by a Specific Antibody Protects Against Colitis-Associated Cancer
by: Hongping Ba, et al.
Published: (2021-10-01)

Tumor Necrosis Factor Inhibitor Discontinuation in Patients with Ankylosing Spondylitis: An Observational Study From the US-Based Corrona Registry
by: Philip J. Mease, et al.
Published: (2018-10-01)

Photothermal transforming agent and chemotherapeutic co-loaded electrospun nanofibers for tumor treatment
by: Zhao J, et al.
Published: (2019-05-01)

A comparative study of intratumoral chemotherapy in advanced childhood common solid tumors
by: Rajeev Rahi, et al.
Published: (2007-01-01)

Understanding the immunopathogenic bases and the clinical approach of the periodic syndrome associated with the tumor necrosis receptor, TRAPS
by: Moreno Zuluaga, Catalina, et al.
Published: (2018-10-01)

Actions of tumour necrosis factor: in vitro cytotoxicity and in vivo toxicity.
Published: (1988)

The Role of Tumor Necrosis Factor α in the Biology of Uterine Fibroids and the Related Symptoms
by: Michał Ciebiera, et al.
Published: (2018-12-01)

The Role of Post-Neoadjuvant Chemotherapy Tumor Volume for Prognostication and Treatment Guidance in Loco-Regionally Advanced Nasopharyngeal Carcinoma
by: Fo-Ping Chen, et al.
Published: (2019-10-01)

Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome—Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA Network
by: Antonio Vitale, et al.
Published: (2021-07-01)

THE POSSIBILITY OF USING TUMOR NECROSIS FACTOR-THYMOSIN-α1 IN NEOADJUVANT CHEMOTHERAPY OF BREAST CANCER
by: L. YU. VLADIMIROVA, et al.
Published: (2016-12-01)

Both Tumor Necrosis Factor Receptor Signaling Pathways Contribute to Mortality but not to Splenomegaly in Generalized Lymphoproliferative Disorder
by: Florian Wiede, et al.
Published: (2014-12-01)

Lack of Evidence for a Direct Interaction of Progranulin and Tumor Necrosis Factor Receptor-1 and Tumor Necrosis Factor Receptor-2 From Cellular Binding Studies
by: Isabell Lang, et al.
Published: (2018-04-01)

The survival rate of therapy with tumor necrosis factor-αinhibitors: main causes and drug substitution tactics
by: E. V. Igolkina, et al.
Published: (2018-12-01)

Screening for latent tuberculosis infection at a rheumatology and medical rehabilitation center in Duhok City, Iraq
by: Shawkat Sabri Yousif, et al.
Published: (2021-01-01)

Ihmor necrosis factor-a inhibitors and cardiovascular risk in rheumatoid arthritis
by: Tatiana Valentinovna Popkova, et al.
Published: (2012-12-01)

Evaluation of Tumor Necrosis Factor Alpha Polymorphism Frequencies in Endometriosis
by: Roshanak Abutorabi, et al.
Published: (2015-10-01)

Assessing the Percent of Necrosis after Neoadjuvant Chemotherapy with 24hr Infusional Cisplatin/3 Days Doxorubicin Intermittent with IfosfamideDoxorubicin for Osteosarcoma
by: Mozhgan Aalam Samimi, et al.
Published: (2014-03-01)

Chronic inhibition of tumor necrosis factor-α with infliximab improves myocardial deformation in parallel with aortic elasticity in rheumatoid arthritis
by: Birgül Ay, et al.
Published: (2015-03-01)

Infliximab enhances the therapeutic effects of 5-fluorouracil resulting in tumor regression in colon cancer
by: Liu F, et al.
Published: (2016-10-01)

Suspected de novo Hepatitis B in a Patient Receiving Anti-Tumor Necrosis Factor Alpha Therapy for the Treatment of Crohn's Disease
by: Tetsuya Ishida, et al.
Published: (2014-01-01)

Pharmacokinetics of Recombinant Human Tumor Necrosis Factor Alpha in the Delivery System
by: A. V. Bateneva, et al.
Published: (2019-09-01)

Impact of therapy with tumor necrosis factor-α inhibitors on the working ability of patients with ankylosing spondylitis
by: Sh. F. Erdes, et al.
Published: (2016-03-01)

There exists only one tumor necrosis factor
by: S. A. Nedospasov
Published: (2021-01-01)

Various types and management of breast cancer: An overview
by: Ganesh N Sharma, et al.
Published: (2010-01-01)

VARIOUS TYPES AND MANAGEMENT OF BREAST CANCER: AN OVERVIEW
by: Ganesh N. Sharma, et al.
Published: (2010-06-01)

Extravasation of Epirubicin chemotherapy from a port-a-cath causing extensive breast necrosis: Sequential imaging findings and management of a breast cancer patient
by: Penelope Moyle, MBChB, MRCP, FRCR, et al.
Published: (2021-11-01)

Nontuberculous Mycobacteria Infections and Anti–Tumor Necrosis Factor-α Therapy
by: Kevin L. Winthrop, et al.
Published: (2009-10-01)

The role of cytokines in the chemotherapy of malignant tumors:the practice of cytokines Refnot® and Ingaron® administration in advanced cancer with multiple metastases
by: V V Bryuzgin, et al.
Published: (2014-03-01)

Numerical optimal control in cancer chemotherapy.
Published: (1998)

Resection of Locally Advanced Pancreatic Neoplasms after Neoadjuvant Chemotherapy with Nab-Paclitaxel and Gemcitabine following FOLFIRINOX Failure
by: Sarah Hahn, et al.
Published: (2017-08-01)

Cannot write session to /tmp/vufind_sessions/sess_e8g2rca4p4nk6rgvchvnk95a3p